Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지

Regulatory effects of Seogakjihwang-tang on Cytokines and Growth Factor Production in PBMC from the Patient with Cerebral infarction under Consciousness Disorders

  • Kim Yo Han (Department of Neuroscience and Internal Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Sung Kang Keyng (Department of Neuroscience and Internal Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Lee Kwang Ro (Department of Neuroscience and Internal Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Lee Sang Kwan (Department of Neuroscience and Internal Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Cheong Sang Su (Department of Neuroscience and Internal Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Kang Sei Young (Department of Neuroscience and Internal Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Lee So Young (Department of Neuroscience and Internal Medicine, College of Oriental Medicine, Wonkwang University)
  • Published : 2003.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Seogakjihwang-tang (SJT) was widely used to treat patients suffering from cerebral infarction. But scientific investigation has been carried out very little. The aim of the present study is to investigate the effect of SJT on the production of various cytokines in the patients with cerebral infarction (CI). We investigated interleukin (IL)-4, IL-10 and transforming growth factor (TGF)-1 in the sera of 27 patients with cerebral infarction under consciousness disorders and 10 normal controls using an originally devised sensitive sandwich enzyme-linked immunosorbent assay (ELISA). We found that plasma levels of IL-4 were slightly elevated in patients with cerebral infarction, whereas plasma levels of IL-10 (P<0.001) and TGF-1 were reduced. Peripheral blood mononuclear cells (PBMC) obtained from the patient with CI were cultured for 24 h in the presence or absence of lipopolysaccharide (LPS) or phytohaemagglutinin (PHA). The amount of IL-4, IL-10 and TGF-1, in culture supernatant, was significantly increased in the LPS or PHA treated cells compared to unstimulated cells (P<0.05), We also show that increased cytokines IL-4, and IL-10 level was significantly inhibited by SJT in a dose-dependent manner. Maximal inhibition rate of IL-4 and IL-10 production by SJT was 45.63.3% and 614.7% for LPS-stimulated cell and 27.31.2% and 83.62% for PHA-stimulated cells, respectively (P<0.05). On the other hand, SJT significantly increased the LPS or PHA-induced TGF-1 production (P<0.05). These data suggest that SJT has a regulatory effect on the cytokines production, which might explain its beneficial effect in the treatment of CI.

Keywords

References

  1. Proc Natl Acad Sci USA v.94 Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Kawamata T;Dietrirh WD;Schallert T;Gotts JE;Cocke RR;Benowitz LI;Finklestein SP
  2. Acta Neuropathol (Ber1) v.86 no.5 Expression of transforming growth factor-beta 1 and interleukin-1 beta mRNA in rat brain following transient forebrain ischemia. Wiessner C;Gehrmann J;Lindholm D;Topper R;Kreutzberg GW;Hossmann KA
  3. J Exp Med v.160 no.2 Activation of human macrophages. Comparison of other cytokines with interferon-gamma. Nathan GF;Prendergast TJ;Wiebe ME;Stanley ER;Platzer E;Remold HG;Welte K;Rubin BY;Murray HW
  4. J Am Acad Dermatol v.23 no.6 Interactions of epidermal cells and T cells in inflammatory skin diseases. Baadsgaard O;Fisher GJ;Voorhees JJ;Cooper KD
  5. Blood v.77 no.9 Interleukin-4: a prototypic immunoregulatory lymphokine. Paul WE
  6. J Immunol v.142 no.5 Promotion of human T lymphocyte proliferation by IL-4. Mitchell LC;Davis LS;Lipsky PE
  7. Blood v.76 no.7 Interleukin-4 (IL4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes. te Velde AA;Huijbens RJ;Heije K;de Vries JE;Figdor CG
  8. Eur J Immunol v.21 no.1 Interleukin 4 induces interleukin 6 production by endothelial cells: synergy with interferon-gamma. Howells G;Pham P;Taylor D;Foxwell B;Feldmann M
  9. J Immunol v.152 no.7 Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. Sempowski GD;Beckmann MP;Derdak S;Phipps RP
  10. Int Arch Allergy Immunol v.107 no.1;2;3 Synthesis of cytokines by eosinophils and their regulation. Lamkhioued B;Aldebert D;Gounni AS;Delaporte E;Goldman M;Capron A;Capron M
  11. J Exp Med v.174 no.5 Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. de Waal Malefyt R;Abrams J;Bennett B;Figdor CG; de Vries JE
  12. Proc Natl Acad Sci U S A v.91 no.18 Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. Geng Y;Gulbins E;Altman A;Lotz M
  13. Immunol Today v.13 no.6 Biological properties of interleukin 10. Howard M;O'Garra A
  14. Hepatology. v.31 no.6 Cold liver ischemia-reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin 10 in mice. Le Moine O;Louis H;Demols A;Desalle F;Demoor F;Quertinmont E;Goldman M;Deviere J
  15. J Immunol Methods v.259 no.1;2 Analysis of transforming growth factor-beta 1 (TGF-beta1) expression in human monocytes infected with Mycobacterium avium at a single tell level by ELISPOT assay. Aung H;Sherman J;Tary-Lehman M;Toossi Z
  16. Mol Genet Metab v.71 no.1;2 Induction of cardiac fibrosis by transforming growth factor-beta(1). Lijnen PJ;Petrov W;Fagard RH
  17. Clin Exp Pharmacol Physlol v.23 no.3 Regulation and interactions of transforming growth factor-beta with cardiovascular cells: implications for development and disease. Saltis J;Agrotis A;Bobik A
  18. Agric Blol Chem v.54 Toxicity of dimethyl sulfoxide as a solvent in bioassay system with HeLa cells evaluated colorimetrically with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide. Ben Trivedi A;Kitabatake N;Doi E
  19. Immunol Today v.12 no.8 Human TH1 and TH2 subsets: doubt no more. Romagnani S
  20. Proc Natl Acad Sci U S A v.88 no.10 Allergen-and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Parronchi P;Macchia D;Piccinni MP;Biswas P;Simonelli C;Maggi E;Ricci M;Ansari AA;Romagnani S
  21. Immunol Today v.15 no.1 Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Zurawski C;de Vries JE
  22. J Allergy Clin Immunol v.109 no.1 Mast cells regulate IFN-gamma expression in the skin and circulating IgE levels in allergen-induced skin inflammation. Alenius H;Laouini D;Woodward A;Mizoguchi E, Bhan AK;Castigli E;Oettgen HC;Geha RS
  23. J Mol Neurosci v.14 no.3 Reduced IL-2 but elevated IL-4, IL-6, and IgE serum levels in patients with cerebral infarction during the acute stage. Kim HM;Shin HY;Jeong HJ;An HJ;Kim NS;Chae HJ;Kim HR;Song HJ;Kim KY;Baek SH;Cho KH;Moon BS;Lee YM
  24. Immunopharmacol Immunotoxicol v.24 no.2 Regulatory effect of cytokine production in asthma patients by SOOJI CHIM(Koryo Hand Acupuncture Therapy). Jeong HJ;Kim BS;Kim KS;Kim HM
  25. Crit Rev Immunol v.17 no.1 Functions of IL-4 and control of its expression. Brown MA;Hural J
  26. Immunopharmacol Immunotoxicol v.24 no.1 Cytokine production regulation in human astrocytes by a herbal combination (Yuldahansotang). Choi JS;Jung SW;Ju JC;Lee SW;Kim KY;Kim HM
  27. J Immunol v.148 no.6 IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. Gazzinelli RT;Oswald IP;James SL;Sher A
  28. Neutol Sci v.22 no.4 Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Perini F;Morra M;Alecci M;Galloni E;Marchi M;Toso V
  29. Eur J Neurol v.6 no.4 High levels of IL-10 secreting cells are present in blood in cerebrovascular diseases. Pelidou SH;Kostulas N;Matusevicius D;Kivisakk P;Kostulas V;Link H
  30. Neurosci Lett v.251 no.3 IL-10 reduces rat brain injury following focal stroke. Spera PA;Ellison JA;Feuerstein GZ;Barone FC
  31. Stroke v.27 no.5 Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans. Krupinski J;Kunlar P;Kumar S;Kaluza J
  32. J Neurosci v.22 no.10 Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. Zhu Y;Yang GY;Ahlemeyer B;Pang L;Che XM;Culmsee C;Klumpp S;Krieglstein J
  33. Stroke v.28 no.3 A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans. Krupinski J;Issa R;Bujny T;Slevin M;Kumar P;Kumar S;Kaluza J
  34. Ann N Y Acad Sci v.962 Protective effects of glial cell line-derived neurotrophic factor in ischemic brain injury. Wang Y;Chang CF;Morales M;Chiang YH;Hoffer J
  35. Am J Gastroenterol v.94 Stromal mast cells and nerve fibers in various chronic liver diseases: relevance to hepatic fibrosis. Matsunaga Y;Kawasaki H;Terada T
  36. F Clin Invest v.90 Transforming growth factor-beta in disease: the dark side of tissue repair. Border WA;Ruoslahti E
  37. J. Neuroimmunol v.18 Hypothesis: a role for tumor necrosis factor in immune-related demyelination and its relevance to multiple sclerosis. Brosnan CF;Selmaj FK;Raine DS
  38. J. Mol. Neurosci v.14 Reduced IL-2 but elevated IL-4, IL-6 and IgE serum levels in patients with cerebral infarction during the acute stage. Kim HM;Shin HY;Jeong HJ;An HJ;Kim NS;Chae HJ;Kim HR;Song HJ;Kim KY;Baek SH;Cho KH;Moon BS;Lee YM
  39. Experimental Neurology v.153 no.1 Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Knoblach Susan M
  40. Clinical neurology Kenneth W. Lindsay;Ian Bone